Search

ProQR to Present at the Evercore ISI HealthConX Conference

Press release

LEIDEN, the Netherlands, Nov. 20, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

November 20, 2018
ProQR Announces Participation in Upcoming Kempen Life Sciences Conference

Press release

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

April 22, 2021
ProQR to Present at Two Investor Conferences in October

Press release

LEIDEN, Netherlands and CAMBRIDGE, Mass., Sept.

September 30, 2019
ProQR Announces Results for the Third Quarter of 2016

Press release

LEIDEN, the Netherlands, Nov. 14, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

November 14, 2016
ProQR to Present at Three Scientific Conferences in April

Press release

… ProQR to Present at Three Scientific Conferences in April … and CAMBRIDGE, Mass., April 22, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … K. Koenekoop, MD, PhD, principle investigator of the ProQR Phase 1/2 STELLAR clinical trial of QR-421a and …

April 22, 2019
ProQR to Present at the JMP Life Sciences Conference

Press release

LEIDEN, the Netherlands, June 14, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

June 14, 2018
ProQR to Present at the Chardan Genetic Medicines Conference

Press release

LEIDEN, the Netherlands, Oct. 02, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

October 02, 2018
ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist

Press release

LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 10, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV.

December 10, 2024
ProQR to Participate in Upcoming Investor Conferences in October 2025

Press release

LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

October 13, 2025
ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares

Press release

LEIDEN, Netherlands and CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

March 31, 2021